Package 63187-228-30

{"route": ["ORAL"], "spl_id": "2fc556b9-f5e3-412e-a250-72dd83490ad6", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["151226"], "spl_set_id": ["e9c4e279-0ef9-4e96-8741-dfe7556953d9"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Proficient Rx LP"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (63187-228-30)", "package_ndc": "63187-228-30", "marketing_start_date": "20190101"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (63187-228-60)", "package_ndc": "63187-228-60", "marketing_start_date": "20190401"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (63187-228-90)", "package_ndc": "63187-228-90", "marketing_start_date": "20190101"}], "brand_name": "Topiramate", "product_id": "63187-228_2fc556b9-f5e3-412e-a250-72dd83490ad6", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "63187-228", "generic_name": "Topiramate", "labeler_name": "Proficient Rx LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "50 mg/1"}], "application_number": "ANDA079162", "marketing_category": "ANDA", "marketing_start_date": "20110101", "listing_expiration_date": "20261231"}